Promising Pathways of Blood Biomarkers: Real-World Impact of Bio-Hermes Study, Upcoming Webinar Hosted by Xtalks
Summary
They will also focus on how the Bio-Hermes study will help in the diagnosis of Alzheimers disease and improve clinical trial enrollment. Register for this webinar today to gain insights about the Bio-Hermes-001 study and the correlation between blood biomarkers and the presence of amyloid plaques in Alzheimers disease. Join Dr. Diana Kerwin, Founder & President, Kerwin Medical Center and PI for Bio-Hermes-001; Dr. Allen Levey, Robert W. Woodruff Professor and Director of the Goizueta Alzheimers Disease Research Center; and Dr. Suzanne Schindler, Associate Professor of Neurology at Washington University School of Medicine, for the live webinar on Tuesday, August 20, 2024, at 10am EDT (3pm BST/UK) For more information, or to register for this event, visit Promising Pathways of Blood Biomarkers: Real-World Impact of Bio-Hermes Study. Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Xtalks helps professionals stay current with industry developments, regulations and jobs.